OTC Switch Offers Firms Opportunities To Diversify Earnings – Morgan Stanley

Rx-to-OTC switches offer drug firms a "meaningful opportunity" to diversify their earnings, which is gaining importance in an "increasingly challenging pharmaceutical landscape" Morgan Stanley market analysts say